rss
Heart 2006;92:579-581 doi:10.1136/hrt.2005.082172
  • Editorial

Role of drug eluting stents in diabetic patients

  1. F Boccara1,
  2. E Teiger2,
  3. A Cohen1
  1. 1Department of Cardiology, Saint Antoine University Hospital. Assistance Publique-Hôpitaux de Paris and Université Paris VI, Paris, France
  2. 2Department of Physiopathology, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris and Université Paris XII, Creteil, France
  1. Correspondence to:
    Dr Franck Boccara
    Cardiology department, Saint-Antoine University and Medical School, Assistance Publique-Hôpitaux de Paris and Université Pierre et Marie Curie (Paris VI), 184, rue du faubourg Saint-Antoine, 75571 Paris Cedex 12, France; franck.boccara{at}sat.aphp.fr
  • Published Online First 31 January 2006

Abstract

There is a clear need for a large multicentre trial comparing the efficacy of the two available drug eluting stents, sirolimus and paclitaxel, in diabetic patients with multivessel disease

Footnotes

  • Published Online First 31 January 2006

Relevant Article

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.